Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer

Henry Gómez, Adrián Martín, Dinesh Chandra Doval et al.|Journal of Clinical Oncology|2007

Cited by 11